Key result
Cardiac magnetic resonance confirmed myocarditis in 53% of acute and 50% of post-acute COVID-19 patients with suspected myocarditis, while also identifying myocardial infarction and cardiomyopathies.
Why the study?
Cardiac injury is commonly reported in COVID-19 patients, and CMR findings needed to be evaluated in patients with suspected myocarditis-like syndrome during the acute versus post-acute phases of infection.
Observational (n=39)
No
Absolute Event Rate: 53% vs 50%
CMR improves diagnostic accuracy in patients with suspected COVID-19 related myocarditis by characterizing ischemic and non-ischemic injury and revealing subclinical cardiomyopathies.
CMR patterns in AMCovS and cPACS remain hypothesis-generating; prospective studies needed before informing clinical decisions.
INTRODUCTION: Cardiac injury is commonly reported in COVID-19 patients, resulting associated to pre-existing cardiovascular disease, disease severity, and unfavorable outcome. Aim is to report cardiac magnetic resonance (CMR) findings in patients with myocarditis-like syndrome during the acute phase of SARS-CoV-2 infection (AMCovS) and post-acute phase (cPACS). METHODS: Between September 2020 and January 2022, 39 consecutive patients (24 males, 58%) were referred to our department to perform a CMR for the suspicion of myocarditis related to AMCovS (n = 17) and cPACS (n = 22) at multimodality evaluation (clinical, laboratory, ECG, and echocardiography). CMR was performed for the assessment of volume, function, edema and fibrosis with standard sequences and mapping techniques. CMR diagnosis and the extension and amount of CMR alterations were recorded. RESULTS: Patients with suspected myocarditis in acute and post-COVID settings were mainly men (10 (59%) and 12 (54.5%), respectively) with older age in AMCovS (58 [48-64]) compared to cPACS (38 [26-53]). Myocarditis was confirmed by CMR in most of cases: 53% of AMCovS and 50% of cPACS with negligible LGE burden (3 [IQR, 1-5] % and 2 [IQR, 1-4] %, respectively). Myocardial infarction was identified in 4/17 (24%) patients with AMCovS. Cardiomyopathies were identified in 12% (3/17) and 27% (6/22) of patients with AMCovS and cPACS, including DCM, HCM and mitral valve prolapse. CONCLUSIONS: In patients with acute and post-acute COVID-19 related suspected myocarditis, CMR improves diagnostic accuracy characterizing ischemic and non-ischemic injury and unraveling subclinical cardiomyopathies.
No takes yet. Share an insight, caveat, or question.
Palmisano et al. (2022) conducted an observational in Suspected myocarditis in acute and post-acute COVID-19 (n=39). Acute SARS-CoV-2 infection (AMCovS) vs. Post-acute phase (cPACS) was evaluated on CMR confirmation of myocarditis. Cardiac magnetic resonance confirmed myocarditis in 53% of acute and 50% of post-acute COVID-19 patients with suspected myocarditis, while also identifying myocardial infarction and cardiomyopathies.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: